Nathaniel Calloway - 04 Apr 2025 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Daniel George, as attorney-in-fact
Issuer symbol
ANEB
Transactions as of
04 Apr 2025
Net transactions value
$0
Form type
4
Filing time
07 Apr 2025, 21:41:31 UTC
Previous filing
10 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 04 Apr 2025 Common Stock 25,000 $1.02 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +3,309 $0.000000 3,309 04 Apr 2025 Common Stock 3,309 $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.